Clovis Oncology Inc (NASDAQ:CLVS)

90.76
Delayed Data
As of May 22
 +0.23 / +0.25%
Today’s Change
35.33
Today|||52-Week Range
102.28
+62.07%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 100.00, with a high estimate of 125.00 and a low estimate of 85.00. The median estimate represents a +10.18% increase from the last price of 90.76.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.06
Sales
$0.00
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.54%
 
 
 
 
 
 
Growthannually -82.83%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account